Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹5.41
0.00 (0.00%)
Extreme VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹45 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹5.15+5.0%
52W High₹29.4-81.6%
Current Price
₹5.41
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹5.14
Upper Circuit₹5.68
Reference Price
₹5.41
Investment Checklist
Trend: Price below most MAs — downtrend
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Doji (BULLISH, strength 2)
3-day momentum: -3.2% — strong downward pressure
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
41%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
5.79
EMA50
6.21
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows3
Lower Highs5
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹5.51
₹6.10
₹6.25
₹6.48
₹6.74
Support (Below)
₹5.15
Volume Analysis
TrendSTABLE
Change-7.00%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹5.36
3% Risk₹5.25
5% Risk₹5.14
7% Risk (Custom)
₹5.03Technical Levels
1x ATR (Volatility)₹5.07
2x ATR (Swing)₹4.73
3x ATR (Trend)₹4.39
Immediate Support₹5.15
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹36.5 Cr | ₹25.6 Cr | ₹21.4 Cr | ₹20.6 Cr |
| Net Profit | ₹-6 Cr | ₹-5.6 Cr | ₹-5.5 Cr | ₹-7.3 Cr |
| EPS | ₹-0.72 | — | ₹-0.66 | ₹-0.88 |
| Operating Profit | ₹1.1 Cr | ₹54,20,000 | ₹9,60,000 | ₹-74,20,000 |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Vivimed Labs Limited | ₹5.41 | +0.00% | — | ₹45 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 27 Dec 2024 | Annual General Meeting | AGM |
| 07 Nov 2023 | Annual General Meeting | AGM |
| 21 Mar 2023 | Annual General Meeting | AGM |
| 10 Feb 2023 | Annual General Meeting | AGM |
| 23 Dec 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for VIVIMEDLAB
View AllNEWS
negative
Business Standard - Markets 119d ago
Vivimed Labs reports consolidated net loss of Rs 16.55 crore in the December 2025 quarter
Sales decline 56.20% to Rs 15.99 crore
VIVIMEDLABHealthcare